This in vitro study examined the role of the METTL3–RFX7 axis in PDGF-BB-stimulated airway smooth muscle cells (ASMCs) as a model of childhood asthma, assessing effects on cell proliferation, migration, invasion, inflammation (IL-6, TNF-α), oxidative stress (ROS, MDA), and macrophage polarization.
RFX7 was elevated in pediatric asthma patient serum and in PDGF-BB-stimulated ASMCs, while METTL3 was downregulated; RFX7 knockdown and METTL3 overexpression each attenuated ASMC proliferation, migration, invasion, IL-6/TNF-α production, ROS/MDA levels, and CD86+ macrophage proportion, with METTL3 acting via YTHDF2-dependent destabilization of RFX7 transcripts.
All functional experiments were conducted in vitro only, with no animal or clinical validation; the study does not report sample sizes for patient serum cohorts or effect sizes with confidence intervals; causal directionality in human disease cannot be established from cell-line data.
This is early-stage mechanistic research; the METTL3–RFX7 axis is not yet ready for clinical application, but it may inform future therapeutic targets for airway remodeling in childhood asthma.